Bradley Singer, MD
Pain Medicine · Grand Island, NENPI 1407054711
Payments from drug & device makers
What this record shows
29 manufacturers reported payments, led by Medtronic at 39.2% of the total. Reporting peaked in 2019 at $2,898 and has fallen 91.6% since, to $244 in 2025.
Across 183 payments — averaging $39.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Nevro Corp.$808
- Abbott$720
- Collegium Pharmaceutical, Inc.$130
- Forte Bio-pharma LLC$114
- plus $958 from 23 others
What the payments were for
- Travel & lodging$2,97341%
- Food & beverage$4,27959%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 46 | $2,842 |
| Boston Scientific | 22 | $1,679 |
| Nevro Corp. | 29 | $808 |
| Abbott | 20 | $720 |
| Collegium Pharmaceutical, Inc. | 9 | $130 |
| Forte Bio-pharma LLC | 6 | $114 |
| Vertex | 4 | $91 |
| Pfizer | 5 | $89 |
| Si-bone, Inc. | 4 | $81 |
| Arbor Pharmaceuticals, Inc. | 5 | $72 |
| Biocomposites Inc | 4 | $71 |
| AbbVie(2 entities) | 4 | $66 |
| SPR Therapeutics, Inc | 2 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Vertos Medical, Inc. | 2 | $44 |
| Tersera Therapeutics LLC | 3 | $42 |
| Conetic Solutions, Inc. | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $31 |
| Spinal Simplicity, LLC | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Saluda Medical Americas, Inc. | 1 | $24 |
| Nalu Medical, Inc. | 1 | $22 |
| Globus Medical | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Siemens Medical Solutions USA, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPERION$1,310
- KYPHON Balloon Kyphoplasty$817
- ADAPTIVESTIM$696
- Proclaim Family of SCS IPGs$290
- INTELLIS$148
- Senza$133
How this compares
$7,252 in reported general payments places this provider in the 60th percentile of 31 pain medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 22 | $49,968 |
| Xtampza ErOxycodone Myristate | 69 | $41,176 |
| Nurtec OdtRimegepant Sulfate | 17 | $27,212 |
| BelbucaBuprenorphine Hcl | 29 | $24,374 |
| Buprenorphine | 113 | $19,304 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 573 | $17,608 |
| OxycontinOxycodone Hcl | 11 | $7,697 |
| Morphine Sulfate ErMorphine Sulfate | 163 | $4,091 |
| Gabapentin | 154 | $4,018 |
| Tramadol Hcl | 314 | $3,212 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 95 | $2,507 |
| Pregabalin | 84 | $2,232 |
| Methocarbamol | 62 | $2,118 |
| Pentazocine-Naloxone HclPentazocine Hcl/Naloxone Hcl | 14 | $1,795 |
| Tizanidine Hcl | 57 | $1,101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $130 | $65,55098 claims |
| AbbVieBotox | $66 | $49,96822 claims |
| PfizerNurtec Odt | $89 | $27,21217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 31 pain medicine providers in Nebraska.
Other pain medicine in Grand Island
- Dongyup LeeGrand Island$11K
- J MeyerGrand Island$2K
- Phillip EssayLincoln$63K
- Austin ReillyElkhorn$34K
- Charles WhittenLincoln$25K
- Matthew StottleOmaha$14K
- John MasseyLincoln$13K
- Liane DonovanLincoln$13K
- Katie BerkyOmaha$12K
- Ihsan BalkayaNorfolk$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.